Tobey J. MacDonald
The George Washington University and Center for Cancer and Immunology Research
Children's Research Institute
Washington
District of Columbia 20010
USA
Name/email consistency: high
- Imatinib blocks migration and invasion of medulloblastoma cells by concurrently inhibiting activation of platelet-derived growth factor receptor and transactivation of epidermal growth factor receptor. Abouantoun, T.J., MacDonald, T.J. Mol. Cancer Ther. (2009)
- Phase I clinical trial of cilengitide in children with refractory brain tumors: Pediatric Brain Tumor Consortium Study PBTC-012. MacDonald, T.J., Stewart, C.F., Kocak, M., Goldman, S., Ellenbogen, R.G., Phillips, P., Lafond, D., Poussaint, T.Y., Kieran, M.W., Boyett, J.M., Kun, L.E. J. Clin. Oncol. (2008)
- Aggressive infantile embryonal tumors. MacDonald, T.J. J. Child Neurol. (2008)
- Phase II study of high-dose chemotherapy before radiation in children with newly diagnosed high-grade astrocytoma: final analysis of Children's Cancer Group Study 9933. MacDonald, T.J., Arenson, E.B., Ater, J., Sposto, R., Bevan, H.E., Bruner, J., Deutsch, M., Kurczynski, E., Luerssen, T., McGuire-Cullen, P., O'Brien, R., Shah, N., Steinbok, P., Strain, J., Thomson, J., Holmes, E., Vezina, G., Yates, A., Phillips, P., Packer, R. Cancer (2005)
- Advances in the diagnosis, molecular genetics, and treatment of pediatric embryonal CNS tumors. MacDonald, T.J., Rood, B.R., Santi, M.R., Vezina, G., Bingaman, K., Cogen, P.H., Packer, R.J. Oncologist (2003)
- Expression profiling of medulloblastoma: PDGFRA and the RAS/MAPK pathway as therapeutic targets for metastatic disease. MacDonald, T.J., Brown, K.M., LaFleur, B., Peterson, K., Lawlor, C., Chen, Y., Packer, R.J., Cogen, P., Stephan, D.A. Nat. Genet. (2001)